0001213900-24-019015.txt : 20240301 0001213900-24-019015.hdr.sgml : 20240301 20240301161609 ACCESSION NUMBER: 0001213900-24-019015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smiths Group International Holdings Ltd CENTRAL INDEX KEY: 0001901425 ORGANIZATION NAME: STATE OF INCORPORATION: X0 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 24709966 BUSINESS ADDRESS: STREET 1: C/O SMITHS GROUP PLC STREET 2: LEVEL 10, 255 BLACKFRIARS ROAD CITY: LONDON STATE: X0 ZIP: SE1 9AX BUSINESS PHONE: 4402070041600 MAIL ADDRESS: STREET 1: C/O SMITHS GROUP PLC STREET 2: LEVEL 10, 255 BLACKFRIARS ROAD CITY: LONDON STATE: X0 ZIP: SE1 9AX ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 ownership.xml X0508 4 2024-02-29 1 0000883984 ICU MEDICAL INC/DE ICUI 0001901425 Smiths Group International Holdings Ltd C/O SMITHS GROUP PLC LEVEL 10, 255 BLACKFRIARS ROAD LONDON X0 SE1 9AX UNITED KINGDOM 0 0 0 1 Former 10% Owner 0 Common Stock 2024-02-29 4 S 0 830000 106.075 D 1670000 D These shares are held directly by Smiths Group International Holdings Limited ("SGIH"). SGIH is a wholly owned subsidiary of Smiths Group plc ("SGP"). SGP is an indirect beneficial owner of the shares. Reporting Owner Name/Address/Relationship to Issuer: Smiths Group plc (SGP), Level 10, 255 Blackfriars Road, London, UK, SE1 9AX; 10% Ownership; Smiths Group International Holdings Limited (SGIH), Level 10, 255 Blackfriars Road, London, UK, SE1 9AX; 10% Ownership. Exhibit 24.1 - Power of Attorney of Smiths Group International Holdings Ltd. /s/ Matthew John Whyte, Attorney-in-Fact 2024-03-01 EX-24.1 2 ea0201043ex24-1_icumedical.htm POWER OF ATTORNEY OF SMITHS GROUP INTERNATIONAL HOLDINGS LTD

Exhibit 24.1

POWER OF ATTORNEY

The undersigned constitutes and appoints Clare Scherrer and Matthew Whyte or any of them acting singly, as the undersigned’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned’s name, place and stead, to sign any and all the Securities and Exchange Commission (the “SEC”) statements of beneficial ownership of securities of Smiths Group International Holdings Limited (the “Company”) on Schedule 13D as required under Section 13 and Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange Act of 1934, as amended, and any amendments thereto, and to file the same with all exhibits thereto, and other documents in connection therewith, with the SEC, the Company and any stock exchange on which any of the Company’s securities are listed, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each act and thing requisite and necessary to be done under said Section 13 and Section 16(a), as fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, may lawfully do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC. The authorization set forth above shall continue in full force and effect until the undersigned revokes such authorization by written instructions to the attorneys-in-fact.

The authority granted hereby shall in no event be deemed to impose or create any duty on behalf of the attorneys-in-fact with respect to the undersigned’s obligations to file a Form ID, Schedule 13Ds and Forms 3, 4 and 5 with the SEC.

Dated: July 28, 2023

SMITHS GROUP INTERNATIONAL HOLDINGS LIMITED

By:	/s/ Matthew Whyte
	Name:	Matthew Whyte
	Title:	Director